LXR receptor modulators

Details LXR receptor modulators LXR receptor modulators

2011-01-18

2011-01-18

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S183000, C514S258100, C514S231200, C514S247000, C514S252010, C514S336000, C514S423000, C544S143000, C544S144000, C544S224000, C544S238000, C544S358000, C546S201000, C546S226000, C546S250000, C546S255000, C548S400000, C548S416000, C548S452000, C548S300100, C548S532000

Reexamination Certificate

active

07872021

ABSTRACT:
Benzenesulfonamide derivative compounds corresponding to the general formula (I):and their pharmaceutically acceptable addition salts; a process for preparation of such compounds; pharmaceutical compositions containing such compounds, and the use of such compounds as a pharmacologically active substance, in particular in the treatment of neurodegenerative diseases, cardiovascular diseases, inflammatory diseases; hypercholesterolemia, and diabetes.

REFERENCES:
patent: 6251932 (2001-06-01), Reichelt et al.
patent: 6559127 (2003-05-01), Dappen et al.
patent: 7465811 (2008-12-01), Lebreton et al.
patent: 2003/0008861 (2003-01-01), Lin et al.
patent: WO 00/54759 (2000-09-01), None
patent: WO02005113542 (2005-12-01), None
“Ambinter Screening Library” 2002: 1505846 , XP-002348255, Jan. 1, 2004.
International Search Report dated Oct. 24, 2005 (Eight (8) pages).

Affiliated with

Also associated with

Rating

LXR receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with LXR receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and LXR receptor modulators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2700621